Contents of this document
- J-Stream CDNext begins offering a feature that automates SSL/TLS certificate management through ACME integration with certificate authorities
- ビッグエムズワイ and an overseas literature service jointly offer a service supporting the development and use of physician-persona conversational AI agents
- VideoStep opens a Nagoya base at STATION Ai
- VideoStep adopted by the Chita Peninsula General Medical Organization
- Total Revenue of Consolidated Subsidiaries17.5 % year on year
- Total Operating Profit of Consolidated Subsidiaries48 % year on year
- Consolidated number of employees704 peopleYear on year against the same period last year+33.0%
- Jストリーム standalone employee count404 peopleYear on year against the same period last year-16.0%
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | ¥6,081 million (YoY +6.5%) |
| Operating profit | ¥414 million (YoY +14.5%) |
| Ordinary income | ¥438 million (YoY +14.2%) |
| Net income | ¥237 million (YoY +17.1%) |
| Gross Profit Margin | 39.1 % |
| Operating profit margin | 6.8 % |
| Selling, general and administrative expenses | ¥1,961 million |
| Results for the three months of the current quarter | Net Sales ¥2,989 million / Revenue YoY (%) 3.4 / Operating profit ¥162 million / Operating Profit YoY (%) -17.8 / Operating profit margin 5.4 % / Gross profit ¥1,151 million / Gross profit yoy_pct 2.2 / Gross Profit Margin 38.5 % |
| Full-year earnings forecast | Net Sales ¥12,702 million / Operating profit ¥920 million / Ordinary income ¥950 million / Net income ¥536 million |
| Progress against full-year forecast | Net Sales 47.9 % / Operating profit 45 % / Ordinary income 46.2 % / Net income 44.3 % |
| Segment results | Pharmaceuticals Sales ¥771 million / Profit Not disclosed / yoy_pct Not disclosed / EVC Sales ¥757 million / Profit Not disclosed / yoy_pct Not disclosed / OTT Sales ¥706 million / Profit Not disclosed / yoy_pct Not disclosed / Total consolidated subsidiaries Revenue YoY (%) 17.5 / Operating Profit YoY (%) 48 |
| Breakdown of Factors Affecting the Change | Labor Costs ¥91 million / Outsourcing expenses ¥166 million / Outsourcing fees (cost of sales) ¥-8 million / Depreciation and amortization ¥-2 million / Royalties ¥16 million / Procurement ¥-23 million / Personnel Expenses ¥30 million / Sales support expenses ¥31 million / Outsourcing fees (SG&A) ¥35 million / Selling and Marketing Expenses ¥1 million |
| Key KPIs | Indicator name Total Revenue of Consolidated Subsidiaries / Value 17.5 % year on year, Indicator name Total Operating Profit of Consolidated Subsidiaries / Value 48 % year on year, Indicator name Consolidated number of employees / Value 704 people / Year on year against the same period last year 33 people, Indicator name Jストリーム standalone employee count / Value 404 people / Year on year against the same period last year -16 people |
| Unit price and quantity metrics | Both the unit price and number of Web seminars held declined slightly. The number of clients using virtual general meetings of shareholders increased, but the unit price fell. Figures: Not disclosed. |
| Number of employees | Number of Employees 704 people / Year on year against the same period last year 33 people / Change during the period 2 people / Hiring plan Hiring was restrained except at VideoStep |
| Annual Dividend | Annual dividend per share 14 Yen / Interim Not disclosed / End of period Not disclosed |
| Capital expenditures | ¥267 million |
| New initiatives | J-Stream CDNext begins offering a feature that automates SSL/TLS certificate management through ACME integration with certificate authorities, ビッグエムズワイ and an overseas literature service jointly offer a service supporting the development and use of physician-persona conversational AI agents, VideoStep opens a Nagoya base at STATION Ai, VideoStep adopted by the Chita Peninsula General Medical Organization |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue growth, including the effects of M&A at consolidated subsidiaries, strong production-related sales, improved productivity, and restrained hiring and reduced outsourcing costs contributed to performance. In the pharmaceutical market, unit prices and the number of Web seminars held declined, but content production, live events, VR and other services at subsidiaries contributed to revenue growth.